Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer.

Kaur, Sumanpreet; Bhattacharyya, Rajasri; Banerjee, Dibyajyoti; Shukla, Jaya.

Afiliación

Kaur S; Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, 160012 India.
Bhattacharyya R; Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, 160012 India.
Banerjee D; Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, 160012 India.
Shukla J; Department of Nuclear Medicine, PGIMER, Chandigarh, 160012 India.

Indian J Clin Biochem ; 36(1): 124-125, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33505137